Repeated clinical success drove shares of GW Pharmaceuticals (NASDAQ: GWPH) about 60% higher in 2016, and an impressive 190% higher than low points in March. If you missed the boat last year, you’ll be happy to know there are at least three reasons this top marijuana stock could continue rising in the new year and beyond.
Image source: Getty Images.